Posters - NCDEU: An Annual Meeting Sponsored by ASCP

Friday, June 1, 2012
8:30 am – 10:00 am Identifying Biomarkers for Personalizing the
(continued) Treatment of Depression – Implementation of
Study Design and Initial Results in Subtype,
Mechanism and Psychological Fields: An iSPOT-D
Report
Frank Lloyd Wright Salon G-H
9:10 am – 9:30 am Prefrontal Dysfunction in Major Depression:
Preliminary Functional Magnetic Resonance
Imaging Results
Leanne Williams, Ph.D., University of Sydney
9:30 am – 9:50 am Emotion Regulation Strategies and Treatment
Response in Major Depressive Disorder: An
iSPOT-D Report
Kateri McRae, Ph.D., University of Denver
9:50 am – 10:00 am General Discussion
Evian Gordon, Ph.D., Brain Resource Ltd.
8:30 am – 10:00 am Reaping the Benefits of Data Pooling and Sharing
to Address Questions in Designing RCT’s and
Predicting Outcomes of Antipsychotic and
Antidepressant Drugs
Frank Lloyd Wright Salon I-J
Chair: Jonathan Rabinowitz, Ph.D., Bar Ilan University
8:30 am – 8:55 am Improving Efficiency of RCT’s of Antipsychotic
Trials: Lessons Learned from the NewMeds
Repository of RCT Data from AstraZeneca,
Janssen, Eli Lilly, Lundbeck, and Pfizer
Jonathan Rabinowitz, Ph.D., Bar Ilan University
8:55 am – 9:20 am Can Genome-wide Pharmacogenetics Help Predict
Response of Antidepressant Treatment for Major
Depressive Disorder: NewMeds Consortium of
Academic and Industry-led Studies
Rudolf Uher, M.D., King’s College London
69